Study Stopped
Futility
Cap Assisted Upper Endoscopy Versus High Definition White Light Endoscopy and Narrow Band Imaging Alone In The Detection Of Visible Lesions Barrett's Esophagus: A Randomized Tandem Study
1 other identifier
interventional
100
1 country
1
Brief Summary
The hypothesis is that the addition of a transparent cap to the end of the endoscope will increase the detection and diagnostic yield of visible lesions in Barrett's esophagus. Thus, the goal of this tandem design trial is to compare the diagnostic yield (DY) of cap assisted endoscopy with that of conventional endoscopy using high definition-white light endoscopy (HD-WLE) and narrow band imaging (NBI) in patients with Barrett's esophagus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 22, 2017
CompletedFirst Submitted
Initial submission to the registry
January 25, 2018
CompletedFirst Posted
Study publicly available on registry
January 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2021
CompletedResults Posted
Study results publicly available
July 29, 2022
CompletedSeptember 1, 2022
August 1, 2022
3.9 years
January 25, 2018
June 2, 2022
August 1, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants Who Had a Diagnostic Yield Obtained
-Diagnostic yield is defined as Barrett's esophagus lesions that were identified and confirmed histologically as low grade dysplasia, high grade dysplasia, intramucosal cancer, or invasive adenocarcinoma
At the time of procedure (day 1)
Secondary Outcomes (4)
Number of Participants With Visible Lesions in EGD With Cap Versus Without Cap
At the time of procedure (day 1)
Number of Participants With High Grade Dysplasia or Esophageal Adenocarcinoma
At the time of procedure (day 1)
Total Procedure Duration in Seconds
At the time of procedure (day 1)
Safety as Measured by Number of Participants With Procedure-related Adverse Events
Through 48 hours after EGD
Study Arms (2)
Arm 1: EGD with cap first, followed by EGD without cap
EXPERIMENTAL-Participants in the first arm will undergo EGD with cap first, followed by EGD without cap in the same procedural period.
Arm 2: EGD without cap first, followed by EGD with cap
EXPERIMENTAL-Participants in the second arm will undergo EGD without cap first, followed by EGD with cap in the same procedural period.
Interventions
-The second endoscopist will be blinded to the results of the initial exam.
-The second endoscopist will be blinded to the results of the initial exam.
Eligibility Criteria
You may qualify if:
- Must be at least 18 years of age.
- Must be patients undergoing standard of care EGD for the confirmation of dysplasia in BE or EET for dysplasia in BE.
- Must be able to understand and willing to sign an IRB-approved written informed consent document.
You may not qualify if:
- Pregnant or breastfeeding.
- Prior endoscopic treatment for BE.
- Unable to tolerate sedation due to medical comorbidities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Vladimir M. Kushnir, M.D.
- Organization
- Washington University School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Vladimir M Kushnir, M.D.
Washington University School of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2018
First Posted
January 31, 2018
Study Start
December 22, 2017
Primary Completion
November 15, 2021
Study Completion
November 17, 2021
Last Updated
September 1, 2022
Results First Posted
July 29, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share